Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,455 | 4,087 | 3,553 | 3,869 | 3,402 |
| Operating Income | -4,455 | -4,087 | -3,553 | -3,869 | -3,402 |
| Other Income | 202 | 431 | 86 | 34 | 37 |
| Pre-tax Income | -4,253 | -3,656 | -3,466 | -3,836 | -3,365 |
| Net Income Continuous | -4,253 | -3,656 | -3,466 | -3,836 | -3,365 |
| Net Income | $-4,253 | $-3,656 | $-3,466 | $-3,836 | $-3,365 |
| EPS Basic Total Ops | -14.29 | -12.32 | -11.76 | -12.89 | -11.48 |
| EPS Basic Continuous Ops | -14.18 | -12.38 | -11.76 | -13.01 | -11.41 |
| EPS Diluted Total Ops | -14.29 | -12.32 | -11.76 | -12.89 | -11.48 |
| EPS Diluted Continuous Ops | -14.18 | -12.38 | -11.76 | -13.01 | -11.41 |
| EBITDA(a) | $-4,455 | $-4,087 | $-3,552 | $-3,869 | $-3,402 |